Investor List:

Top Therapeutics Seed Investors in London (13)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Therapeutics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Pablo Lubroth, Investor at Hummingbird Ventures
Pablo Lubroth
Sweet spot: $2.8M
Range: $500K - $5.0M
Investors in London, Investors in New York (NY)
Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in DeepTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in DeepTech (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in Digital Health (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in DeepTech (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in DeepTech (Series A), Investors in Therapeutics (Series A), Investors in Digital Health (Series A), Investors in DeepTech (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in DeepTech (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Therapeutics (Series B), Investors in DeepTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Series B), Investors in DeepTech (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in London (Other Lists), Investors in New York City (Other Lists)
Photo of Devika Thapar, General Partner at Wilbe Capital
Devika Thapar
Wilbe Capital·General Partner
Sweet spot: $250K
Range: $100K - $500K
Investors in California, Investors in Switzerland, Investors in Boston / New England, Investors in Boston (MA), Investors in Munich (Germany), Investors in London
Investors in Therapeutics (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in Material Science (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in AgTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Hardware (Pre-seed), Investors in Material Science (Pre-seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Hardware (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in Semiconductors (Pre-seed), Investors in Material Science (Pre-seed), Investors in BioTech (Pre-seed), Investors in DeepTech (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Hardware (Pre-seed), Investors in AgTech (Pre-seed), Investors in BioTech (Pre-seed), Investors in ClimateTech/CleanTech (Pre-seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in Material Science (Seed), Investors in Semiconductors (Seed), Investors in Semiconductors (Seed), Investors in Material Science (Seed), Investors in DeepTech (Seed), Investors in AgTech (Seed), Investors in Hardware (Seed), Investors in EnergyTech (Seed), Investors in Therapeutics (Seed), Investors in DeepTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Hardware (Seed), Investors in AgTech (Seed), Investors in EnergyTech (Seed), Investors in BioTech (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in Semiconductors (Seed), Investors in Material Science (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in DeepTech (Seed), Investors in EnergyTech (Seed), Investors in Hardware (Seed), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in Boston / New England (Other Lists), Investors in Investors who were founders (Other Lists)
Photo of Andrew Kozlov, Managing Partner at 4BIO Capital
Andrew Kozlov
4BIO Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Pharmaceuticals (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Dima Kuzmin, Managing Partner at 4BIO Capital
Dima Kuzmin
4BIO Capital·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Jonathan Tobin, Partner at Brandon Capital Partners
Jonathan Tobin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Andrea Zitna, Partner at Speedinvest
Andrea Zitna
Speedinvest·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Photo of Kieran Mudryy, Partner at 4BIO Capital
Kieran Mudryy
4BIO Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)
Photo of Owen Smith, Partner at 4BIO Capital
Owen Smith
4BIO Capital·Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in London
Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in London (Other Lists)